{"id":6339,"date":"2017-04-01T05:00:58","date_gmt":"2017-04-01T09:00:58","guid":{"rendered":"https:\/\/medicarereport.org\/?p=6339"},"modified":"2017-03-31T10:11:53","modified_gmt":"2017-03-31T14:11:53","slug":"cost-of-drugs-list-price-versus-net-price","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=6339","title":{"rendered":"Cost of Drugs: List Price versus Net Price"},"content":{"rendered":"<p><span style=\"margin: 0px; color: #0a0a0a; letter-spacing: 0.25pt; font-family: 'Helvetica','sans-serif'; font-size: 12pt;\">In a recent report by PhRMA, found that over 50% of out-of-pocket spending by commercially insured patients is based on the list price of a medicine, rather than the negotiated, lower net price. <a href=\"http:\/\/www.biopharmadive.com\/news\/drug-prices-phrma-payers-report-blame\/439349\/\" target=\"_blank\">Read article here&#8230;<\/a><\/span><\/p>\n<pre style=\"border: 1px solid #eaeaea; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; font-stretch: inherit; line-height: 1.4; font-family: 'Courier 10 Pitch', Courier, monospace; font-size: 14px; font-style: normal; font-weight: normal; margin: 0px 0px 20px; outline: 0px; padding: 20px; vertical-align: baseline; background-color: #ffffff; overflow: auto; white-space: pre-wrap; color: #444444; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px;\"><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>In a recent report by PhRMA, found that over 50% of out-of-pocket spending by commercially insured patients is based on<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-6339","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/6339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6339"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/6339\/revisions"}],"predecessor-version":[{"id":6340,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/6339\/revisions\/6340"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}